J9053
HCPCSInj belantamab mafodot blmf
Official HCPCS Level II long descriptor
Injection, belantamab mafodotin-blmf, 0.1 mg
HCPCS Level II code J9053 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj belantamab mafodot blmf
Added to HCPCS: 2026-07-01
Nearby codes in J9
- J9045Carboplatin injection
- J9046Inj, bortezomib, dr. reddy's
- J9047Injection, carfilzomib, 1 mg
- J9048Inj, bortezomib freseniuskab
- J9049Inj, bortezomib, hospira
- J9050Carmustine injection
- J9051Inj, bortezomib (maia)
- J9052Inj, carmustine (accord)
- J9054Inj bortezomib boruzu 0.1 mg
- J9055Cetuximab injection
- J9056Inj, vivimusta, 1 mg
- J9057Inj., copanlisib, 1 mg
- J9060Cisplatin 10 mg injection
- J9061Inj, amivantamab-vmjw
- J9062Inj amivantamab 5mg hyaluron
- J9063Inj, elahere, 1 mg
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.